ÌìÃÀ´«Ã½

Background

Sung Hun Bae joined the Department of Pharmaceutical Sciences at ÌìÃÀ´«Ã½â€™s School of Pharmacy and Pharmaceutical Sciences in 2024 and became a member of Dr. Zhang’s laboratory. He completed his PhD in Pharmaceutical Sciences from Ajou University in South Korea, where his doctoral research focused on preclinical pharmacokinetic studies and physiologically based pharmacokinetic (PBPK) modeling. His work examined changes in drug absorption, distribution, metabolism, and excretion (ADME) under various disease conditions, including renal failure, inflammatory bowel disease and liver injury.

Bae’s research integrates in vitro, in vivo, and in silico approaches to understand how pathological states alter drug disposition. He is also interested in pharmacometric approaches such as population PK/PD analysis, translational pharmacology, and model-informed drug development (MIDD). In addition, he has expertise in LC–MS/MS method development and enzyme activity assays, providing a diverse experimental foundation for pharmacokinetic research.

At ÌìÃÀ´«Ã½, his research is expanding toward maternal–infant health, with a focus on predicting drug transfer into breast milk and estimating infant exposure, aiming to improve drug safety in vulnerable populations.

Research Interests

• Physiologically based pharmacokinetic (PBPK) modeling
• Population PK/PD analysis
• Maternal–infant drug transfer and lactation pharmacology
• Model-informed drug development (MIDD)